Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Outfits Scottish Metabolomics Facility with Four Mass Specs

Premium

This story originally ran on March 18.

Thermo Fisher Scientific this week said it is providing four mass spectrometers to the Scottish Metabolomics Facility.

The four instruments are an LTZ Orbitrap Velos with ETD and FAIMS source, a DSQ-II GC-MS, and two Exactive LC-MS benchtop systems.

Funded by the Scottish Universities Life Science Alliance, ScotMet is run jointly by the Universities of Glasgow and Strathclyde.

In a statement, Jennifer Bell, executive director of SULSA, said "ScotMet aims to provide a world-class facility staffed by experts in metabolomics who work closely with leaders in the fields of genomics, proteomics and bioinformatics to offer training, sample analysis and collaboration on experimental design and data handling. This advances the growing field of metabolomics and to support systems initiatives across Scotland."

According to Thermo Fisher, the mass accuracy and sensitivity of the LTQ Orbitrap Velos, equipped with multiple fragmentation modes, such as ETD, as well as CID, HCD, and PQD, allows researchers to accelerate their research. For high-throughput metabolite screening, the fast polarity switching of the Exactive allows "effective data collection in positive and negative modes," the firm said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.